Cardiac G-protein receptor kinase activity: effect of a beta-adrenergic receptor antagonist.
Hammond
H K
HK
Veterans Administration Medical Center, San Diego, California, USA.
Ping
P
P
Insel
P A
PA
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D017607:Aluminum Compounds / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D017298:Bisoprolol / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology; D004789:Enzyme Activation; D005459:Fluorides / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000378:metabolism*; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism*; D013552:Swine
D000319:Adrenergic beta-Antagonists; D017607:Aluminum Compounds; D011943:Receptors, Adrenergic, beta; D005576:Colforsin; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D020794:Receptor Protein-Tyrosine Kinases; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D005459:Fluorides; D017298:Bisoprolol; C032311:aluminum fluoride